Approximately one in 200,000 people in France is diagnosed with narcolepsy every year, according to a study. “This evaluation…
Articles by Marisa Horak, MS
While people with narcolepsy often face challenges at school and at work, they can be successful with support, understanding,…
Advocates around the globe are marking World Narcolepsy Day today with campaigns to correct common misconceptions about the condition, reduce…
Alkermes is now accepting research grant applications focused on narcolepsy and other neurological conditions. The biopharmaceutical company announced …
A new review, by an international team of scientists, confirms what was found in two large, late-stage clinical trials: The…
Dosing strategies aimed at gradually raising drug levels in the body, instead of increasing levels all at once, may help…
When Karla Dzienkowski’s daughter started experiencing abnormal restlessness and daytime sleepiness as a preteen, Dzienkowski initially assumed that these…
The U.S. Food and Drug Administration (FDA) has approved Takeda‘s oral therapy Orzeyful (oveporexton) for adults with narcolepsy…
Looking at patterns of electrical activity in the brain during sleep may help to distinguish between children with narcolepsy…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to Lu AH69593, an experimental oral therapy…